Featured News

bioteXcel consulting has recently been launched in the UK by it founder Elisabetta Fineschi. The company boasts a global footprint by having a team of professionals spanning China, India, Europe, US and Canada. This article discusses the beginning of bioteXcel and the visions of its founder. (more)

Genmab A/S (OMX: GEN) reports today that the last patient to be included in the planned interim analysis (N=132 patients) in the pivotal Phase III clinical trial of ofatumumab (HuMax-CD2) in refractory chronic lymphocytic leukemia (CLL) has now received the last scheduled treatment. (more)

infoQuant Ltd brings microarray technology closer to clinical use with its latest release of copy number analysis and interpretation software oneClickCGH and CGH Fusion for microarray-based comparative genomic hybridization tests (array CGH). (more)